Poster Session 2-25 MM: Others (1)

[PS2-25-3] Clinical outcomes of relapsed myeloma, dual refractory to bortezomib and IMiDs in KMF registry

Ryosuke Fujiwara^1,23, Hirokazu Tanaka^1,23, Kentaro Serizawa^1,23, Hitomi Kaneko^2,23, Yuji Shimura^3,23, Kensuke Ohta^4,23, Shin-Ichi Fuchida^5,23, Aya Nakaya^6,23, Junya Kanda^7,23, Hideo Yagi^8,9,23, Katsuya Wada^10,23, Satoru Kosugi^11,23, Nobuhiko Uoshima^12,23, Hirohiko Shibayama^13,23, Takae Kohara^13,23, Eiji Nakatani^14,23, Hitoji Uchiyama^15,23, Yoko Adachi^16,23, Masato Iida^17,23, Tsuneyoshi Hamada^18,23, Mitsuhiro Matsuda^19,23, Akifumi Takaori-Kondo^7,23, Shosaku Nomura^20,23, Chihiro Shimazaki^5,23, Masayuki Hino^21,23, Junya Kuroda^4,23, Masafumi Taniwaki^22,23, Kazunori Imada^2,23, Yuzuru Kanakura^13,23, Itaru Matsumura^1,23 (1.Hematolog and Rheumatology, Kindai University, Osaka, Japan, 2.Hematology, Osaka Red Cross Hospital, Osaka, Japan, 3.Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 4.Hematology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan, 5.Hematology, JCHO Kyoto Kuramaguchi Medical Center, Kyoto, Japan, 6.Hematology and Oncology, Kansai Medical University Medical Center, Osaka, Japan, 7.Hematology and Oncology, Kyoto University, Kyoto, Japan, 8.Hematology and Oncology, Nara Prefecture General Medical Center, Nara, Japan, 9.Hematology, Kindai University Nara Hospital, 10.Hematology, Matsushita Memorial Hospital, Osaka, Japan, 11.Internal Medicine (Hematology), Toyonaka Municipal Hospital, Osaka, Japan, 12.Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan, 13.Hematology and Oncology, Osaka University, Osaka, Japan, 14.Biostatistics and Data Science, Osaka University, Osaka, Japan, 15.Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan, 16.Hematology, Kobe Central Hospital, Hyogo, Japan, 17.Internal Medicine, Kawasaki Hospital, Hyogo, Japan, 18.Hematology, Kyoto-Katsura Hospital, Kyoto, Japan, 19.Hematology, PL General Hospital, Osaka, Japan, 20.First Department of Internal Medicine, Kansai Medical University, Osaka, Japan, 21.Hematology, Osaka City University, Osaka, Japan, 22.Molecular Diagnostics Therapeutics, Kyoto Prefectural University of Medicine, Kyoto, Japan, 23.Kansai Myeloma Forum, Osaka, Japan)